The Human Papilloma Virus Vaccination: Turkish Mothers’ Views
Objectives: This study was conducted in order to analyze the knowledge and opinions of mothers of daughters in Turkey regarding the human papilloma virus (HPV) vaccine.
Methods: This descriptive study was conducted at 8 public family health centers at primary health care institutions affiliated with the Ministry of Health located in Ataşehir, in Istanbul province. A total of 252 mothers of daughters participated. A sociodemographic characteristics form and an HPV vaccine evaluation questionnaire were used to collect the data. The data were analyzed using percentage, frequency distribution, a chi-square test, and Fisher’s exact test.
Results: Most of the participating mothers were between the ages of 28 and 47 years (68.7%), had a high school graduate education or less (82.5%), were not employed (67.9%), and had a low family income (57.6%). The majority (95.6%) had no experience with cervical cancer in their family, 60.7% had never heard of HPV infection, 72.2% did not know that HPV infection is related to cervical cancer, 54.8% had never heard of the HPV vaccine, 89.7% had not been advised to have their daughters vaccinated, and 98.8% had not yet had their daughters vaccinated. Among the factors influencing the mothers’ information about HPV infection were age (p=0.021), education level (p<0.001), work status (p<0.001), mothers’ marriage age (p<0.001) and family income level (p=0.009). It was determined that a greater education level positively influenced the mothers’ intention to get the HPV vaccine for their daughter (p=0.044).
Conclusion: This study revealed that the mothers had very limited knowledge of the HPV vaccine and that health professionals do not sufficiently inform parents on this subject. It was also found that the high cost of the vaccine and other influences had a negative impact on intention to pursue obtaining the vaccine.
1.Dunne EF, Markowitz LE, Saraiya M, Stokley S, Middleman A, Unger ER, et al; Centers for Disease Control and Prevention (CDC). CDC grand rounds: Reducing the burden of HPV-associated cancer and disease. MMWR Morb Mortal Wkly Rep 2014; 63:69–72.
2. Katki HA, Schiffman M, Castle PE, Fetterman B, Poitras NE, Lorey T, et al. Five-year risk of recurrence after treatment of CIN 2, CIN 3, or AIS: performance of HPV and Pap cotesting in posttreatment management. J Low Genit Tract Dis 2013;17:S78–84.
3. Ozgul N, Tuncer M, Abacioglu M, Gultekin M. Estimating prevalence of genital warts in Turkey: survey among KETEM-affiliated gynecologists across Turkey. Asian Pac J Cancer Prev 2011;12:2397–400.
4. Petrosky E, Bocchini JA Jr, Hariri S, Chesson H, Curtis CR, Saraiya M, et al. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep 2015;64:300–4.
5. Tonguc E, Gungor T, Var T, Kavak E, Yucel M, Uzunlar O. Knowledge about HPV, relation between HPV and cervix cancer and acceptance of HPV vaccine in women in eastern region of Turkey. J Gynecol Oncol 2013;24:7–13. [CrossRef]
6. Bonanni P, Boccalini S, Bechini A. Efficacy, duration of immunity and cross protection after HPV vaccination: a review of the evidence. Vaccine 2009;27 Suppl 1:A46–53. [CrossRef]
7. Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, et al. Comprehensive control of human papillomavirus infections and related diseases. Vaccine 2013;31 Suppl 7:H1–31.
8. Dursun P, Kuficu E, Zeyneloğlu HB. Maternal Factors affecting HPV Vaccine Acceptance for their adolescent children aged between 10 and 15. Türk Jinekoloji ve Obstetrik Derneği Dergisi. 2009;6:206–10.
9. Kim SJ, Kim S, Kang KA, Oh J, Lee MN. Development of a simulation evaluation tool for assessing nursing students' clinical judgment in caring for children with dehydration. Nurse Educ Today 2016;37:45–52. [CrossRef]
10. Kang HS, Moneyham L. Attitudes, intentions, and perceived barriers to human papillomavirus vaccination among Korean high school girls and their mothers. Cancer Nurs 2011;34:202–8.
11. Ilter E, Celik A, Haliloglu B, Unlugedik E, Midi A, Gunduz T, et al. Women's knowledge of Pap smear test and human papillomavirus: acceptance of HPV vaccination to themselves and their daughters in an Islamic society. Int J Gynecol Cancer 2010;20:1058–62.
12. Pitts M, Smith A, Croy S, Lyons A, Ryall R. Singaporean women's knowledge of human papillomavirus (HPV) and attitudes toward HPV vaccination. Women & Health 2009;49:334–51.
13. Lee PW, Kwan TT, Tam KF, Chan KK, Young PM, Lo SS, et al. Beliefs about cervical cancer and human papillomavirus (HPV) and acceptability of HPV vaccination among Chinese women in Hong Kong. Prev Med 2007;45:130–4. [CrossRef]
14. Davlin SL, Berenson AB, Rahman M. Correlates of HPV knowledge among low-income minority mothers with a child 9-17 years of age. J Pediatr Adolesc Gynecol 2015;28:19–23. [CrossRef]
15. WHO. Cancer control: knowledge into action. WHO guide for effective programmes. Available at: http://www.who.int/cancer/modules/en/. Accessed Oct 31, 2017.
16. van Keulen HM, Otten W, Ruiter RA, Fekkes M, van Steenbergen J, Dusseldorp E, et al. Determinants of HPV vaccination intentions among Dutch girls and their mothers: a cross-sectional study. BMC Public Health 2013;13:111. [CrossRef]
17. Trim K, Nagji N, Elit L, Roy K. Parental Knowledge, Attitudes, and Behaviours towards Human Papillomavirus Vaccination for Their Children: A Systematic Review from 2001 to 2011. Obstet Gynecol Int 2012;2012:921236. [CrossRef]